Crossmark

Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial protocol

Crossref DOI link: https://doi.org/10.1186/s12885-022-09429-z

Published Online: 2022-03-26

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Park, Soo Jin

Kong, Tae Wook

Kim, Taehun

Lee, Maria

Choi, Chel Hun

Shim, Seung-Hyuk

Yim, Ga Won

Lee, Seungmee

Lee, Eun Ji

Lim, Myong Cheol

Chang, Suk-Joon

Lee, Sung Jong

Lee, San Hui

Song, Taejong

Lee, Yoo-Young

Kim, Hee Seung http://orcid.org/0000-0003-1238-7604
Nam, Eun Ji
Funding

Funding for this research was provided by:

Johnson and Johnson
License Information

Text and Data Mining valid from 2022-03-26

Version of Record valid from 2022-03-26
More Information

Article History

Received: 26 August 2021

Accepted: 20 March 2022

First Online: 26 March 2022

Declarations

:

: This study protocol was approved by the institutional review board of each participating institution as follows: Seoul National University Hospital (No. H-2002-101-1103); Ajou University Hospital (No. AJURB-MED-INT-20-476); Seoul Metropolitan Government-Seoul National University Boramae Medical Center (No. 30–2020-117); Samsung Medical Center (No. 2020–08–079-003); Konkuk Universit Hospital (No. 2021–03-059); Seoul St. Mar”s Hospital (No. KC20MDDF0946); Wonju Severance Christian Hospital (No. CR321031); Kangbuk Samsung Hospital (No. KBSMC 2021–1–060-003); Severance Medical Center (No. 1–2020-0054).The informed consent form, including consent for publication, will be signed by each patient.

: Not applicable.

: None declared.

Document is current

Any future updates will be listed below